Core Insights - Klotho Neurosciences, Inc. has been awarded the Fifth Annual BioTech Breakthrough Award in the "Cell Therapy Innovation of the Year" category for its innovative gene and cell therapies targeting neurodegenerative diseases [1][2]. Company Overview - Klotho Neurosciences focuses on developing transformative therapies using a patented form of the human Klotho gene (s-KL) to treat conditions such as ALS, Alzheimer's disease, and Parkinson's disease [2][4]. - The company's therapies aim to address the underlying mechanisms of neuronal aging, potentially slowing, halting, or reversing disease progression [2]. Industry Context - The BioTech Breakthrough Awards recognize innovation in the life sciences and biotechnology sectors, highlighting excellence in biopharma, therapeutics, genomics, diagnostics, and research tools [3]. - As the global population ages, there is an increasing demand for therapies that target the root causes of age-related diseases, positioning Klotho to meet this challenge [3].
Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award